Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Clinipace Worldwide, a digital clinical research organization (dCRO), engaged in clinical research services for biopharmaceutical and medical device firms, has expanded its regulatory and strategic development expertise with the acquisition of Regulus Pharmaceutical Consulting.
Subscribe to our email newsletter
The Regulatory Affairs and Quality Assurance consultancy, Regulus is expected to work as the Regulatory Affairs, Strategic Development, and Quality Assurance consultancy division of Clinipace Worldwide.
With is acquisition, Clinipace has increased its employee force by 20% with new team members adding an average of 18 years experience in the life science industry.
Following the transition, Regulus president Brenda Fielding will take up the charge of Executive Vice President of Regulatory Affairs for Clinipace Worldwide.
Clinipace Regulatory Affairs executive vice president Brenda Fielding said their combined offerings are a perfect fit for a client in need of comprehensive product development solutions.
"Together, we can ensure all relevant disciplines are involved in a clinical development project, from initial concept to regulatory strategy and submissions, quality systems implementation, clinical operations, through to the final delivery of the completed project," Fielding said.